期刊文献+

终端干热法灭活凝血因子类制品中细小病毒的工艺验证 被引量:6

Validation of Procedure for Inactivation of Parvovirus in Coagulation Factor Products by Terminal Dry Heating
原文传递
导出
摘要 目的验证终端干热法灭活凝血因子类制品中细小病毒的灭活工艺,并对其灭活效果进行评价。方法以猪细小病毒(Porcine parvovirus,PPV)为指示病毒,模拟凝血因子类制品生产工艺中病毒灭活的工艺,采用96孔板微量细胞病变法检测残余病毒滴度,验证终端干热法灭活病毒的效果。结果 3家企业生产的人凝血因子Ⅷ制品经100℃加热30min灭活,病毒滴度分别下降2.01~2.31、≥3.92和3.13~3.50LgTCID50/0.1ml;冻干与加热联合作用,病毒滴度分别下降2.82~3.00、≥4.24和4.00~4.12LgTCID50/0.1ml;5家企业生产的人纤维蛋白原经100℃加热30min灭活,病毒滴度分别下降3.50~3.63、2.56~2.70、3.06~3.57、3.00~3.25和≥3.75LgTCID50/0.1ml;冻干与加热联合作用,病毒滴度分别下降4.00~4.12、3.12~3.46、4.04~4.56、3.50~3.75和≥4.63LgTCID50/0.1ml。结论终端干热法对凝血因子类制品中的细小病毒具有一定的灭活作用,但由于工艺复杂、影响因素较多,不同企业生产的同类制品的病毒灭活效果不尽相同。 Objective To validate the procedure for inactivation of parvovirus in coagulation factor products by terminal dry heating and evaluate the inactivation effect.Methods The inactivation procedure during manufacturing of coagulation factor products was simulated using porcine parvovirus(PPV)as an indicator.The residual virus titer was determined by micro-CPE on a 96-well microtiter plate to validate the inactivation efficacy by terminal dry heating.Results The virus titers in human coagulation Ⅷ manufactured by three manufacturers after inactivation by heating at 100℃ for 30 min decreased by 2.01 ~ 2.31,≥ 3.92 and 3.13 ~ 3.50 LgTCID50 /0.1 ml,while those by lyophilization combined with heating decreased by 2.82 ~ 3.00,≥ 4.24 and 4.00 ~ 4.12 LgTCID50 /0.1 ml,respectively.However,the virus titers in human fibrinogen manufactured by five manufacturers after inactivation by heating at 100℃ for 30 min decreased by 3.50 ~ 3.63,2.56 ~ 2.70,3.06 ~ 3.57,3.00 ~ 3.25 and ≥ 3.75 LgTCID50 /0.1 ml,while those by lyophilization combined with heating decreased by 4.00 ~ 4.12,3.12 ~ 3.46,4.04 ~ 4.56,3.50 ~ 3.75 and ≥ 4.63 LgTCID50 /0.1 ml,respectively.Conclusion Terminal dry heating showed a certain inactivation effect on the PPV in coagulation factor products.However,because of complicated procedure and multiple influencing factors,the virus inactivation efficacies of products of the same kind by various manufacturers were different.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第9期1018-1020,1027,共4页 Chinese Journal of Biologicals
关键词 终端干热法 病毒灭活 血浆凝血因子 细小病毒属 工艺验证 Terminal dry heating Virus inactivation Plasma coagulation factor Parvovirus Procedure validation
  • 相关文献

参考文献9

  • 1中华人民共和国卫生部.关于转发血液制品去除或灭活病毒处理方法与检测效果指标的函.卫药政发[1994]第264号.
  • 2卫生部司(局)文件.关于下发"血液制品去除或灭活病毒方法及其验证和论证程序"的通知[S].卫药生发[1997]第433号.
  • 3国家药品监督管理局.关于印发《血液制品去除/灭活病毒技术方法及验证指导原则》的通知,国药监注[2002]160号.
  • 4赵雄,尹惠琼,章金刚.纤维蛋白原制品病毒灭活方法研究进展[J].中国输血杂志,2008,21(2):141-144. 被引量:13
  • 5卜凤荣(综述),于军(综述),宿艳笋(综述).血浆制品中人细小病毒B19的灭活/去除研究进展[J].国际生物制品学杂志,2009(6):320-323. 被引量:1
  • 6张延莹,李宏昊,姜燕.血液制品灭活及去除病毒工艺[J].中国生化药物杂志,2002,23(4):207-209. 被引量:12
  • 7Prikhod'ko GG. Dry-heat sensitivity of human B19 and porcine parvoviruses [J]. Transfusion, 2005, 45 (10) : 1692-1693.
  • 8Kim IS, Choi YW, Kang Y, et al. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor Ⅷ concentrate prepared from human plasma[J]. J Microbiol Biotechnol 2008, 18 (5) : 997-1003.
  • 9Roberts PL, El Hana C, Saldana J. Inactivation of parvovirus B19 and model viruses in factor Ⅷ by dry heat treatment at 80 degree C[J]. Tansfusion, 2006, 46 (9):1648-1650.

二级参考文献51

  • 1章金刚.生物技术产品的病毒安全性[J].中国医药生物技术,2007,2(2):81-84. 被引量:7
  • 2Kaufmann B, Simpson AA, Rossmann MG. The structure of human parvovirus B19 [J]. Proc Natl Acad Sci U S A, 2004, 101 (32) :11628-11633.
  • 3Schmidt I, Blumel J, Seitz H, et al. Parvovirus B19 DNA in plasma pools and plasma derivatives [ J]. Vox Sang, 2001, 81 (4) :228-235.
  • 4Parsyan A, Candotti D. Human erythrovirus BI9 and blood transfusion-an update [ J ]. Transfus Meal,2007, 17 (4) :263-278.
  • 5Blurnel J, Schmidt I, Effenberger W, et al. Parvovirus B19 transmission by heat-treated clotting factor concentrates [ J ]. Transfusion, 2002, 42( 11 ) : 1473-1481.
  • 6Blurnel J, Stuhler A, Dichtetmtiller H. Kinetics of inactivation human parvovirus BI9 and porcine parvovirus by dry-heat treatment [ J ]. Transfusion, 2008, 48 (4) :790-791.
  • 7Yunoki M, Tsujikawa M, Urayama T, et al. Heat sensitivity of human parvovirus B19 [J]. Vox Sang, 2003, 84(3) :164-169.
  • 8Yunoki M, Urayama T, Tsujikawa M, et al. Inactivation of parvovirus B19 by liquid heating incorporated in the manufacturing process of human intravenous immunoglobiu preparations [ J ]. Br J Haematol, 2005, 128(3) :401-404.
  • 9Hattori S, Yunoki M, Tsujikawa M, et al. Variability of parvovirus B19 to inactivation by liquid heating in plasma products [J]. Vox Sang, 2007, 92(2) :121-124.
  • 10Blumel J, Schmidt I, Willkommen H, et al. Inactivation of parvovirus B19 during pasteurization of human serum albumin [ J]. Transfusion, 2002, d2 ( 8 ) : 1011-1018.

共引文献22

同被引文献55

  • 1由少华.动物源原料医疗器械病毒和传染因子携带风险的监控[J].中国医疗器械杂志,2004,28(5):356-358. 被引量:9
  • 2史新立,谭芳奕,王召旭,奚廷斐,解慧琪,杨志明,戴建武.疯牛病病原体研究及动物源性医疗器械产品安全性思考[J].中国修复重建外科杂志,2006,20(11):1138-1144. 被引量:25
  • 3World Federation of Hemophilia. World Federation of Hemophilia Report on the Annual Global Survey 2011 [R/OL]. http://wwwl. wtla.org/publications / files / pdf- 1488.pdf. [2013-03-05 ].
  • 4国家药品监督管理局.血液制品去除/灭活病毒技术方法及验证指导原则[S].国药监注(2002)160号.2002-05-07.
  • 5de Mendoza C, Altisent C, Aznar JA, et al. Emerging viral infections a potential threat for blood supply in the 21st century [J]. AIDS Rev, 2012, 14 (4): 279-289.
  • 6Norja P, Lassila R, Makris M. Parvovirus transmission by blood products-a cause for concern [J]. Br J Haematol, 2012, 159 (4): 385-393.
  • 7Roberts PL, Dunkerley C, McAuley A, et al. Effect of manu- facturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII [J]. Vox Sang, 2007, 92 (1): 56-63.
  • 8国药监注[2002]160号.血液制品去除/灭活病毒技术方法及验证指导原则.
  • 9Henriques I,Monteiro F,Meireles E,et al.Prevalence of parvovirusB19 and hepatitis A virus in Portuguese blood donors.Transfusionand Apheresis Science,2005,33:305-309.
  • 10World Health Organization.Guidelines on viral inactivation and re-moval procedures intended to assure the viral safety of human bloodplasma products.WHO Technical Report,Series No.924,2004.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部